Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Plos One
|
April 24, 2025
The reliability of medical illness reporting in a randomized clinical trial
Rachelle Morgenstern, Avi Reichenberg, Benjamin Kummer, et al.
Frontiers in Psychiatry
|
May 29, 2019
Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis
Paul Allen, Holly Moore, Cheryl M Corcoran, et al.
Schizophrenia (Heidelberg, Germany)
|
April 26, 2024
Differences in schizophrenia treatments by race and ethnicity-analysis of electronic health records
Candice Medina, Ayooluwa Akinkunmi, Nevaeh Bland, et al.
Epilepsy & Behavior : E&B
|
November 26, 2013
Longitudinal association between epilepsy and schizophrenia: a population-based study
Eyal Fruchter, Ori Kapara, Avi Reichenberg, et al.
European Child & Adolescent Psychiatry
|
June 27, 2014
Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis
Marinos Kyriakopoulos, Argyris Stringaris, Sofia Manolesou, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 28, 2014
How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses
Tiago Reis Marques, Stephen Z Levine, Avi Reichenberg, et al.
Psychiatric Genetics
|
May 19, 2005
Paternal age and intelligence: implications for age-related genomic changes in male germ cells
Dolores Malaspina, Avi Reichenberg, Mark Weiser, et al.
Intelligence
|
January 17, 2015
Thinking positively: The genetics of high intelligence
Nicholas G Shakeshaft, Maciej Trzaskowski, Andrew McMillan, et al.
Psychopharmacology
|
December 12, 2018
An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients
James Gilleen, Yakub Farah, Cate Davison, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 9, 2012
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund, Paul D Morrison, Judith Nottage, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Plos One
|
April 24, 2025
The reliability of medical illness reporting in a randomized clinical trial
Rachelle Morgenstern, Avi Reichenberg, Benjamin Kummer, et al.
Frontiers in Psychiatry
|
May 29, 2019
Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis
Paul Allen, Holly Moore, Cheryl M Corcoran, et al.
Schizophrenia (Heidelberg, Germany)
|
April 26, 2024
Differences in schizophrenia treatments by race and ethnicity-analysis of electronic health records
Candice Medina, Ayooluwa Akinkunmi, Nevaeh Bland, et al.
Epilepsy & Behavior : E&B
|
November 26, 2013
Longitudinal association between epilepsy and schizophrenia: a population-based study
Eyal Fruchter, Ori Kapara, Avi Reichenberg, et al.
European Child & Adolescent Psychiatry
|
June 27, 2014
Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis
Marinos Kyriakopoulos, Argyris Stringaris, Sofia Manolesou, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 28, 2014
How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses
Tiago Reis Marques, Stephen Z Levine, Avi Reichenberg, et al.
Psychiatric Genetics
|
May 19, 2005
Paternal age and intelligence: implications for age-related genomic changes in male germ cells
Dolores Malaspina, Avi Reichenberg, Mark Weiser, et al.
Intelligence
|
January 17, 2015
Thinking positively: The genetics of high intelligence
Nicholas G Shakeshaft, Maciej Trzaskowski, Andrew McMillan, et al.
Psychopharmacology
|
December 12, 2018
An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients
James Gilleen, Yakub Farah, Cate Davison, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 9, 2012
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund, Paul D Morrison, Judith Nottage, et al.
Page
of 1